Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-06-04 Regulatory Filings
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
LIFE: Lifecare ASA has filed application for a new patent
Regulatory Filings Classification · 1% confidence The document is a press release from Lifecare ASA announcing that the company has filed an application for a new patent with the European Patent Office (EPO) regarding sensor technology applicable beyond glucose monitoring. This type of announcement, detailing specific corporate actions like patent filings, R&D progress, or strategic developments, does not fit the definitions for formal financial reports (10-K, IR, ER), meeting materials (AGM-R, DEF 14A), or transaction reports (DIV, POS, SHA). It is a general corporate update. Since there is no specific category for 'Patent Filing Announcement' or 'R&D Update', and it is not a general regulatory filing fallback (RNS) or a management discussion (MDA), the closest fit among the provided options for a specific, non-financial corporate event announcement is often the general Regulatory Filings (RNS) category, or if it were a very short announcement about a report being available, RPA. However, this document is a detailed press release about a specific corporate event (patent filing). Given the options, and recognizing that many non-standard corporate news items default to a general regulatory/news category, RNS (Regulatory Filings) is the most appropriate general category for this type of news release that isn't covered by the more specific financial or governance codes. It is not a Report Publication Announcement (RPA) because it is announcing an action (filing a patent), not the publication of a financial report.
2024-06-04 English
Lifecare ASA: Mandatory notification of trade by primary insiders and close associates
Share Issue/Capital Change Classification · 1% confidence The document text consists of structured tables detailing transactions involving 'person discharging managerial responsibilities/person closely associated' (insiders) of Lifecare ASA. Specifically, it reports the 'Allocation of subscription rights in rights issue' for several associated parties (Joacim Holter, Cimter AS, Teigland Eiendom AS, Hannibal Invest AS). This pattern—reporting personal share transactions or holdings changes by directors and executives—is the defining characteristic of Director's Dealing reports, which are typically filed under regulations like MAR in Europe or Form 4 in the US. Based on the provided definitions, 'Director's Dealing (Code: DIRS)' is the most appropriate classification.
2024-05-30 English
Lifecare ASA: Mandatory notification of trade by primary insiders and close associates
Director's Dealing Classification · 1% confidence The document title explicitly states "MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDERS AND CLOSE ASSOCIATES". It references a rights issue and states that PDMR-forms (Persons Discharging Managerial Responsibilities) related to the allocation of subscription rights to primary insiders are attached. This content directly relates to transactions or holdings by company directors/executives/insiders. This aligns perfectly with the definition for Director's Dealing (Code: DIRS). Although it mentions attachments, the core subject matter is insider trading notification, which is more specific than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2024-05-30 English
Lifecare ASA: Mandatory notification of trade by primary insiders and close associates
Director's Dealing Classification · 1% confidence The document is titled "Lifecare ASA: Mandatory notification of trade by primary insiders and close associates" and explicitly mentions the attachment of "PDMR-forms related to allocation of subscription rights to primary insiders and close associates of primary insiders in the Rights Issue." PDMR (Persons Discharging Managerial Responsibilities) notifications concern personal share transactions by directors and executives. This directly aligns with the definition of Director's Dealing (DIRS). Although it mentions a rights issue (CAP), the core content and purpose of this specific announcement is the notification of insider transactions related to that issue.
2024-05-30 English
LIFE Lifecare CEO presents at Redeye Growth Day 2024
Regulatory Filings Classification · 1% confidence The document is a short press release announcing that the CEO of Lifecare ASA will be presenting at the 'Redeye Growth Day 2024' event. It provides the date, time, and a link to follow the presentation live and view the replay. This is not a full financial report (like 10-K or IR), nor is it a formal earnings release (ER). It is an announcement about the company's participation in an investor-focused event, which aligns best with an Investor Presentation (IP) or, given the context of an external conference presentation, it could be classified as a general announcement related to investor relations. Since the content describes the presentation itself and the company's technology, and the presentation materials are likely the core information being shared, 'Investor Presentation' (IP) is a strong candidate if the actual slides were attached or linked. However, since this text is purely an announcement *about* the presentation happening at an external event, and it doesn't contain the actual presentation slides or detailed financial data, it functions as a notification to investors about upcoming engagement. Given the options, and applying the 'MENU VS MEAL' rule (this is an announcement, not the full presentation), it is closest to a general regulatory/investor announcement. If the actual presentation slides were included, it would be IP. As it stands, it's an announcement of participation in an investor event. Since there is no specific category for 'Presentation Announcement', and it is clearly investor-facing, I will check if it fits 'IP' or 'RPA'. It is announcing an event where an investor presentation will occur. If the actual presentation slides were attached, it would be IP. Since this is just the announcement text, and it's not a standard regulatory filing, 'RPA' (Report Publication Announcement) is often used for announcements about investor-related materials being released or presented. However, 'IP' is defined as 'Investor Presentation'. Given the context of a CEO presenting the 'latest development of the company' at a 'Growth Day', the core subject matter is an investor presentation. I will classify it as IP, assuming the linked material is the presentation itself, or as the closest fit for investor-focused material dissemination, but I must acknowledge the ambiguity. Given the short length and focus on an external event, 'RPA' (Report Publication Announcement) is technically safer if the actual slides are not present, as it announces the event where the presentation occurs. Let's re-evaluate: The document *is* the announcement of the presentation. If the actual presentation slides were attached, it would be IP. Since it's just the announcement text, it's an announcement about investor material. I will lean towards RPA as it announces the event/material release, but IP is also plausible if the linked material is the presentation. Given the nature of these events, the linked material is almost certainly the presentation slides. I will classify it as IP, as the subject matter is the presentation itself.
2024-05-30 English
LIFE Lifecare CEO presents at Redeye Growth Day 2024
Report Publication Announcement Classification · 1% confidence The document is a short announcement stating that the CEO of Lifecare will participate in and present at the 'Redeye Growth Day 2024'. It provides details about the event, the company's technology, and contact information. It is not a full financial report (like 10-K or IR), an earnings release (ER), or a formal regulatory filing. Since it announces the CEO's participation in an investor-focused event where a presentation will be given, it strongly aligns with an Investor Presentation (IP) or, more accurately based on the context of announcing participation in a third-party investor event, it functions as a general announcement related to investor relations. However, given the options, the content is an announcement *about* a presentation, not the presentation itself, nor is it a standard regulatory filing. If the presentation slides were attached, it would be IP. Since it's just an announcement of participation, and it doesn't fit other specific categories like DIV, ER, or DIRS, it is best classified as a general Regulatory Filing (RNS) or potentially related to Investor Presentation (IP) if we assume the intent is to signal upcoming investor material. Given the nature of announcing participation in a growth day event, which is a form of investor outreach, and the short length (Rule 2), it is most likely a general announcement. I will classify it as RNS as it is a general corporate update/announcement that doesn't fit the more specific categories like ER or IP (which usually implies the material itself is attached).
2024-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.